VERRICA PHARMACEUTICALS INC (VRCA)

US92511W1080 - Common Stock

0.7  0 (-0.37%)

After market: 0.7014 +0 (+0.2%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
9.21M5.12M9.03M12.00M0.00
Cost Of Goods
2.39M746.00K730.00KN/AN/A
Gross Profit
6.82M4.38M8.31MN/AN/A
Operating Expenses
81.93M67.60M29.60M42.91M40.18M
Research and Development
15.99M20.30M12.20M15.93M15.67M
Selling, General, and Administrative Expenses
65.94M47.30M17.41M26.98M24.51M
Operating Income
-75.11M-63.22M-21.29M-30.91M-40.18M
Interest Income/Expense
-7.36M-1.22M-1.70M-4.17M-2.51M
Other Income/Expense
18.00K-14.00K-60.00KN/A0.00
Non Recurring Items
N/A-2.54M-1.44MN/AN/A
Income Before Taxes
-84.99M-67.00M-24.49M-35.08M-42.69M
Income Tax
N/AN/A0.00N/AN/A
Net Income
-84.99M-67.00M-24.49M-35.08M-42.69M
EBITDA
-74.19M-62.67M-20.84M-30.67M-40.14M
 
Per Share Data
EPS Diluted Total Ops
-1.83-1.48-0.72-1.30-1.71
Non GAAP EPS
-1.83-1.46-0.79-1.29-1.71
 
Statistics
Gross Profit Margin
74.08%85.44%92.03%N/AN/A
Profit Margin
-922.81%-1307.47%-271.21%-292.33%N/A
Operating Profit Margin
-815.50%-1233.84%-235.77%-257.58%N/A

All data in USD

Charts